Valeant Stock
VRX Stock: The Technical Analyst vs The Fundamental Analyst Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock was downgraded on December 14 by a JPMorgan Chase & Co. (NYSE:JPM) analyst citing valuation concerns. It caused the share price to fall by 10.75% that same day. The timing of this downgrade comes two days after…
VRX Stock: Staging an Advance Putting hard-earned dollars into an investment like Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock isn't easy, especially since the stock has been nothing more than a weapon of wealth destruction. In August 2015, VRX stock traded as high as $263.81, and it took less…
Validation and a Couple Wins for VRX Stock Valeant Pharmaceuticals Intl Inc (NYSE:VRX) must be feeling some measure of validation as the U.S. Securities and Exchange Commission (SEC) has levied a $15.0 million fine at Allergan plc (NYSE:AGN) for failing to disclose news of friendlier bids during a hostile takeover…
Valeant's Sell-Offs to L'Oreal and Sanpower Boosted VRX Stock Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is starting 2017 off on a good note, with VRX stock up over six percent by early afternoon trading on Tuesday. The boost came as a result of several big sales that the company was able to make,…
Can VRX Stock Rise Again? Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is down 4.5% on Wednesday as billionaire William Ackman’s Pershing Square Capital Management LP cut its stake in the company and several executives departed. Pershing is the largest investor in VRX stock, although the recent move has put its stake in…
Another Blow for VRX Stock At this point, it doesn't seem that Valeant Pharmaceuticals Intl Inc (NYSE:VRX, TSE:VRX) could buy good news if it offered half of its VRX stock. The company was down five percent on Monday after the U.S. Food and Drug Administration (FDA) approved a generic version of "Nitropress."…
Is Trump Going to Kill Pharma and Valeant Stocks? President-elect Donald Trump may not be the friend that the pharmaceutical industry had hoped for. Despite gaining in the early days following his election, the NASDAQ Biotechnology Index is down three percent on Wednesday as Trump vows to reduce drug prices.…
Valeant Pharmaceuticals Intl Inc (NYSE:VRX, TSE:VRX) just cannot catch a break these days. VRX stock is down another 7.5% as a deal to sell off its stomach medication fell through. Japan’s Takeda Pharmaceutical Co Ltd (TYO:4502) was in talks with Valeant to acquire Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) from the company…
Valeant Takes Another Blow Valeant Pharmaceuticals Intl Inc (NYSE:VRX) can't seem to catch a break. The company dropped another 4.75% today as the embattled pharmaceutical producer was once again downgraded to "Underperform" from "Neutral" by Irina Koffler at Mizuho Securities Co., Ltd., where she believes investors are reaching the end…
VRX Stock: Bottom Fishing Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock made headlines last week when it reported its earnings and, to the dismay of the bulls, earnings were disappointing as Valeant missed on both the top and bottom lines. Valeant management guided lower as they now expect total…
Valeant Stock Could Benefit from Trump Presidency Valeant Pharmaceuticals Intl Inc (TSE:VRX) has made huge losses and huge gains in the span of 24 hours. Valeant stock lost 22% on election day and gained back almost eight percent the day after. What happened? Donald Trump won. A Donald Trump presidency…